ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2013

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

13,595Medicare Part D Prescriptions Filled, Including Refills

Rank: 148 out of 1904

$795K Total Retail Price of All Prescriptions

Rank: 170 out of 1904

661 Patients Receiving at Least One Drug in Part D
82% Patients 65 Years and Older
47% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg 81928cdb0ebe162ff75cf405bfacadd396bf3ec84bc467b6f3e612dd63daa776 Average for
this specialty
in Indiana
Lower avg 72b1978e1dcc0b845f89d17d692cfff7aeaf8d8bce70310d8bfc535db2daf62a

Schedule Two
Controlled Substances

4% of this provider’s 661 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

11% of this provider’s 661 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$58 was the average price of a prescription from this provider, compared to $61 among peers.

Prescriptions per Patient

21 is the average number of prescriptions (including refills) per patient, compared to an average of 19.


This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

B

A benzodiazepine, or tranquilizer. More » The American Geriatrics Society says these drugs increase the risk of cognitive impairment, delirium, falls and fractures in older adults.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled with Refills Prescriptions
to 65+
Patients Recieving this Drug Category For this Prescriber For All Prescribers in
This Specialty in Indiana
LEVOTHYROXINE SODIUM 582 523 116 1 1
OMEPRAZOLE 343 321 73 2 5
AMLODIPINE BESYLATE 310 298 70 3 6
SIMVASTATIN 308 261 76 4 4
WARFARIN SODIUM 289 278 35 5 14
LISINOPRIL 282 264 57 6 3
HYDROCODONE-ACETAMINOPHEN 282 228 63 S3 6 2
FUROSEMIDE 249 249 46 8 7
METFORMIN HCL 244 194 66 9 9
CARVEDILOL 209 193 47 10 24
ATENOLOL 186 162 44 11 19
TRAMADOL HCL 180 139 53 12 18
DONEPEZIL HCL 179 167 30 13 32
LOSARTAN POTASSIUM 179 160 47 13 21
CITALOPRAM HBR 177 172* 28 15 22
ALLOPURINOL 173 168* 36 16 31
METOPROLOL TARTRATE 172 161 33 17 12
NAMENDA 172 150 23 17 28
MELOXICAM 171 146 42 19 29
TAMSULOSIN HCL 168 142 29 20 26
ATORVASTATIN CALCIUM 167 162* 47 21 8
CLOPIDOGREL 162 148 29 22 20
PANTOPRAZOLE SODIUM 158 142 31 23 27
NYSTATIN 152 152 11 24 96
PRAVASTATIN SODIUM 149 122 36 25 10
METOPROLOL SUCCINATE 143 138* 28 26 16
SERTRALINE HCL 141 97 28 27 25
POTASSIUM CHLORIDE 136 120 30 28 17
CEPHALEXIN 128 109 69 29 58
KLOR-CON M20 122 122 22 30 59
ESCITALOPRAM OXALATE 119 99 25 31 39
ALPRAZOLAM 113 79 22 B 32 15
HYDROCHLOROTHIAZIDE 113 89 28 32 11
LOSARTAN-HYDROCHLOROTHIAZIDE 111 106* 27 34 48
DOXYCYCLINE HYCLATE 106 94 62 35 119
GABAPENTIN 106 83 23 35 13
POLYETHYLENE GLYCOL 3350 104 104 19 37 50
TORSEMIDE 103 98* 18 38 122
NOVOLOG FLEXPEN 101 <11 <11 39 138
ALENDRONATE SODIUM 97 97 17 40 35
PREDNISONE 92 87* 39 41 40
SPIRONOLACTONE 91 80 19 42 60
IPRATROPIUM-ALBUTEROL 90 85* 22 43 110
CLONIDINE HCL 85 80* 19 44 66
LEVEMIR FLEXPEN 81 76* 13 45 135
ZETIA 75 63 13 46 80
NEXIUM 74 42 13 47 37
AZITHROMYCIN 74 69* 45 47 46
CRESTOR 74 69* 18 47 33
TRAZODONE HCL 73 59 15 50 47
CLONAZEPAM 73 54 16 B 50 44
LORAZEPAM 72 55 22 B 52 36
CYMBALTA 71 45 13 53 34
EXELON 70 65* 12 54 123
ISOSORBIDE MONONITRATE ER 68 63* 15 55 64
GLIPIZIDE ER 67 62* 15 56 104
JANUVIA 67 62* 15 56 69
CIPROFLOXACIN HCL 65 60* 36 58 65
MIRTAZAPINE 65 54 12 58 57
FENTANYL 65 32 13 S2 58 74
DIOVAN 64 59* 16 61 61
ZOLPIDEM TARTRATE 64 40 14 61 30
RANITIDINE HCL 63 58* 16 63 43
ROPINIROLE HCL 62 57* 11 64 75
NOVOFINE AUTOCOVER 62 <11 <11 64 250
LISINOPRIL-HYDROCHLOROTHIAZIDE 62 57* 18 64 23
LANTUS 62 57* 15 64 55
TRIAMTERENE-HCTZ 61 56* 15 68 52
AMITRIPTYLINE HCL 61 <11 <11 R 68 76
LEVOFLOXACIN 57 52* 34 70 71
BD ULTRA-FINE PEN NEEDLE 57 52* 14 70 106
KLOR-CON M10 56 <11 <11 72 145
PIOGLITAZONE HCL 54 41 12 R 73 94
SPIRIVA 53 48* 12 74 62
AMITIZA 52 <11 <11 75 224
SYNTHROID 51 46* 16 76 42
KLOR-CON 10 51 46* 12 76 130
LANTUS SOLOSTAR 50 45* 13 78 72
About This Data

Prescribing data from Medicare’s prescription drug benefit, known as Part D, was compiled and released by the Centers for Medicare and Medicaid Services, the federal agency that oversees the program. ProPublica combined that data with additional information released by CMS. The data for 2013 includes nearly 1.4 billion prescriptions written by 1.3 million doctors, nurses and other providers. This database lists about 410,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths of these prescriptions went to patients 65 and older; the rest were for disabled patients Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to checkup@propublica.org and we will update your information. If you have other questions about this data, send a note to checkup@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Feb. 18, 2015.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.